Sign In
Buy EVGN
$0.471
-0.0184 (-3.76%)
At Close: Jul 31, 2026
Evogene Schedules Third Quarter 2025 Financial Results Release
09:00am, Thursday, 06'th Nov 2025
Zoom conference call scheduled for November 20, 2025, 9:00 AM ET REHOVOT, Israel , Nov. 6, 2025 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a pioneering company in computational chemistr
EverGen Infrastructure Provides Operations and Development Updates
07:13pm, Friday, 26'th Sep 2025
VANCOUVER, British Columbia--(BUSINESS WIRE)--EverGen Infrastructure Corp. (“EverGen” or the “Company”) (TSXV: EVGN) today provided an update on operations across its renewable natural gas (�
Evogene to Present at H.C. Wainwright 27th Annual Global Investment Conference in New York
07:00am, Thursday, 28'th Aug 2025
REHOVOT, Israel , Aug. 28, 2025 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology and chemistry company, today announced that Ofer Haviv, Evogene's President an
EverGen Infrastructure Reports Q2 2025 Results
09:42pm, Thursday, 21'st Aug 2025
VANCOUVER, British Columbia--(BUSINESS WIRE)--EverGen Infrastructure Corp. (“EverGen” or the “Company”) (TSXV: EVGN) (OTCQB: EVGIF), today reported financial results as at and for Q2 2025. All
EverGen Infrastructure Announces Dates for 2025 Second Quarter Financial Results and Conference Call
06:28pm, Tuesday, 19'th Aug 2025
VANCOUVER, British Columbia--(BUSINESS WIRE)--EverGen Infrastructure Corp. (“EverGen” or the “Company”) (TSXV: EVGN) (OTCQX: EVGIF), today announced plans to release its 2025 second quarter fi
Evogene Ltd. (EVGN) Q2 2025 Earnings Call Transcript
01:31pm, Tuesday, 19'th Aug 2025
Evogene Ltd. (NASDAQ:EVGN ) Q2 2025 Earnings Conference Call August 19, 2025 9:00 AM ET Company Participants Ofer Haviv - CEO, President & Director Yaron Eldad - Chief Financial Officer Unidentified C
Evogene Reports Second Quarter 2025 Financial Results
07:00am, Tuesday, 19'th Aug 2025
Conference call and webcast: today, August 19, 2025, 9:00 am ET Financial Highlights: The financial results for the first half of 2025 of Lavie Bio, a subsidiary of Evogene and the MicroBoost AI for A
Evogene and Professor Ehud Gazit of Tel Aviv University Announce a Collaboration to Develop New Therapeutics for Metabolic Diseases
07:00am, Tuesday, 12'th Aug 2025
A failure in metabolite breakdown leads to their ordered self-assembly into pathological aggregates, such as in Tyrosinemia and Gout. REHOVOT, Israel , Aug. 12, 2025 /PRNewswire/ -- Evogene Ltd.
Evogene Schedules Second Quarter 2025 Financial Results Release
07:00am, Tuesday, 29'th Jul 2025
Zoom conference call scheduled for August 19, 2025, 9:00 AM ET REHOVOT, Israel , July 29, 2025 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeti
Evogene Announces Completion of Transaction for the Sale of Lavie Bio's Activity to ICL
07:00am, Tuesday, 08'th Jul 2025
REHOVOT, Israel , July 8, 2025 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company utilizing cutting-edge artificial intelligence and predictive biology
EverGen Infrastructure Corp. Announces Appointment of Maria O'Sullivan as Interim CFO
02:00am, Friday, 27'th Jun 2025
VANCOUVER, British Columbia--(BUSINESS WIRE)--EverGen Infrastructure Corp. (“EverGen” or the “Company”) (TSXV: EVGN) is pleased to announce the appointment of Maria O'Sullivan as its Interim C
The new model addresses the challenge of identifying novel small molecules that meet multiple product criteria, an essential requirement for pharma and agriculture applications REHOVOT, Israel , June
EverGen Infrastructure Corp. Announces Participation in the 2025 Canadian Climate Investor Conference
06:19pm, Monday, 09'th Jun 2025
Vancouver, British Columbia--(Newsfile Corp. - June 9, 2025) - EverGen Infrastructure Corp. (TSXV: EVGN), a Canadian renewable energy company specializing in waste-to-energy projects, announced today
EverGen Infrastructure Reports Q1 2025 Results
08:14pm, Friday, 30'th May 2025
VANCOUVER, British Columbia--(BUSINESS WIRE)--EverGen Infrastructure Corp. (“EverGen” or the “Company”) (TSXV: EVGN) (OTCQX: EVGIF), today reported financial results as at and for Q1 2025. All
Evogene Ltd. (EVGN) Q1 2025 Earnings Call Transcript
02:08pm, Wednesday, 21'st May 2025
Evogene Ltd. (NASDAQ:EVGN ) Q1 2025 Earnings Conference Call May 21, 2025 9:00 AM ET Company Participants Ofer Haviv - President and Chief Executive Officer Yaron Eldad - Chief Financial Officer Opera
